Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Thrombosis Research|December 16, 2014
The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor developmentEsther Rabizadeh, Izhack Cherny, Doron Lederfein, et al.
Clinical & Experimental Metastasis|May 29, 2008
Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)Nataly Tarasenko, Abraham Nudelman, Igor Tarasenko, et al.
Acta Haematologica|April 19, 2017
Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center ExperienceAnna Gurevich-Shapiro, Sharon Tzadok, Alina Rosenberg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 14, 2003
Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expressionRima Dardik, Arieh Solomon, Joseph Loscalzo, et al.
Plos One|October 11, 2014
Increased activity of cell membrane-associated prothrombinase, fibrinogen-like protein 2, in peripheral blood mononuclear cells of B-cell lymphoma patientsEsther Rabizadeh, Izhack Cherny, Ofir Wolach, et al.
Plos One|March 3, 2012
Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumorNataly Tarasenko, Suzanne M Cutts, Don R Phillips, et al.
American Journal of Medical Genetics. Part A|April 23, 2004
Gene responsible for mitochondrial myopathy and sideroblastic anemia (MSA) maps to chromosome 12q24.33Kari Casas, Yelena Bykhovskaya, Emebet Mengesha, et al.
Seminars in Thrombosis and Hemostasis|August 25, 2016
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and SuccessesManuel Carcao, Katsuyuki Fukutake, Aida Inbal, et al.
Fertility and Sterility|March 2, 2002
Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndromeMordechai Dulitzky, Shlomo B Cohen, Aida Inbal, et al.
Thrombosis and Haemostasis|July 29, 2010
Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophagesDániel Töröcsik, Lajos Szeles, György Paragh, et al.
Pageof 4